Press Releases

Company News
View Summary Acura Pharmaceuticals Advances LTX-03 and its LIMITx™ Technology
Oct 9, 2017
PDF 20.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Presenting New LIMITx™ Clinical Data at the 19th Annual Rodman & Renshaw Conference
Sep 11, 2017
PDF 19.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Present at the 19th Annual RODMAN & RENSHAW Conference
Aug 31, 2017
PDF 12.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Second Quarter 2017 Financial Results
Aug 14, 2017
PDF 25.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Second Quarter 2017 Financial Results Conference Call on August 15, 2017
Aug 3, 2017
PDF 12.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Raises $4.0 Million in a Private Placement
Jul 24, 2017
PDF 18.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Advances LTX-04 and its LIMITx™ Technology
Jun 28, 2017
PDF 21.4 KB Add to Briefcase
View Summary Acura Pharmaceutical Initiates Second Clinical Study on LTX-04
May 18, 2017
PDF 18.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces First Quarter 2017 Financial Results
May 12, 2017
PDF 25.7 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Fourth Quarter 2016 and Full Year 2016 Financial Results
Mar 31, 2017
PDF 28.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed® Products
Mar 17, 2017
PDF 18.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market
Feb 15, 2017
PDF 19.4 KB Add to Briefcase
View Summary Acura Pharmaceuticals Exploring Strategic Alternatives
Jan 3, 2017
PDF 16.4 KB Add to Briefcase
View Summary Acura Pharmaceutical Provides Development Update on its LIMITx(TM) Technology
Dec 14, 2016
PDF 19.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Third Quarter 2016 Financial Results
Nov 14, 2016
PDF 28.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Third Quarter 2016 Financial Results Conference Call on November 15, 2016
Nov 9, 2016
PDF 10.7 KB Add to Briefcase
View Summary KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion(R) Abuse-Deterrent Technology
Oct 18, 2016
PDF 20.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Second Quarter 2016 Financial Results
Aug 8, 2016
PDF 27.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Webcast on July 14, 2016 to Discuss Additional Data From Study AP-LTX-400
Jul 11, 2016
PDF 12.0 KB Add to Briefcase
View Summary Acura Pharmaceutical's LIMITX(TM) Technology Successfully Confirms Oral Abuse Deterrence Capabilities
Jun 8, 2016
PDF 23.6 KB Add to Briefcase
Showing 1-20 of 131 Page: 1 2 3 4 5 ... 7  Next 20
Add to Briefcase = add release to Briefcase